Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,581 | 691 | 98.8% |
| Education | $135.28 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,226 | 30 | $0 (2024) |
| Novo Nordisk Inc | $1,140 | 76 | $0 (2024) |
| ABBVIE INC. | $837.01 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $822.56 | 45 | $0 (2024) |
| Lilly USA, LLC | $809.95 | 67 | $0 (2024) |
| PFIZER INC. | $807.08 | 67 | $0 (2024) |
| Amgen Inc. | $495.05 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $393.26 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $377.49 | 32 | $0 (2022) |
| GlaxoSmithKline, LLC. | $371.23 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,555 | 87 | Lilly USA, LLC ($186.77) |
| 2023 | $1,162 | 70 | Lilly USA, LLC ($235.52) |
| 2022 | $1,443 | 75 | Novo Nordisk Inc ($238.91) |
| 2021 | $1,959 | 105 | AbbVie Inc. ($248.64) |
| 2020 | $1,396 | 78 | AstraZeneca Pharmaceuticals LP ($217.09) |
| 2019 | $1,523 | 84 | AstraZeneca Pharmaceuticals LP ($396.49) |
| 2018 | $1,197 | 77 | PFIZER INC. ($177.47) |
| 2017 | $1,482 | 120 | PFIZER INC. ($178.22) |
All Payment Transactions
696 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Neuromodulation | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Oncology | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $39.56 | General |
| Category: Wound Care | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.94 | General |
| 10/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Obesity | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Endocrinology | ||||||
| 09/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.32 | General |
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardio-renal | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,051 | 1,369 | $163,330 | $101,256 |
| 2022 | 9 | 1,175 | 1,483 | $169,570 | $107,287 |
| 2021 | 11 | 1,190 | 1,501 | $160,000 | $101,296 |
| 2020 | 10 | 1,176 | 1,477 | $134,762 | $86,996 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 270 | 270 | $47,250 | $33,677 | 71.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 271 | 501 | $50,100 | $27,641 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 258 | $43,080 | $21,974 | 51.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 264 | 264 | $5,280 | $4,694 | 88.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 22 | $6,600 | $4,687 | 71.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $4,000 | $3,198 | 80.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $3,420 | $2,872 | 84.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $3,600 | $2,512 | 69.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 320 | 320 | $55,975 | $40,760 | 72.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 305 | 558 | $55,800 | $30,995 | 55.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 206 | $35,020 | $16,007 | 45.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 309 | 309 | $6,180 | $5,507 | 89.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $4,725 | $4,446 | 94.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 26 | 26 | $5,200 | $4,254 | 81.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $3,610 | $3,094 | 85.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 12 | $2,550 | $1,738 | 68.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $510.00 | $487.11 | 95.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 235 | 235 | $40,750 | $30,538 | 74.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 268 | 479 | $47,900 | $26,945 | 56.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 279 | $47,430 | $23,880 | 50.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 95 | 97 | $6,590 | $6,209 | 94.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 26 | 26 | $4,940 | $4,287 | 86.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 233 | 233 | $4,660 | $4,238 | 91.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 18 | 18 | $3,600 | $2,974 | 82.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 95 | 97 | $2,425 | $1,603 | 66.1% |
About Dr. David Gannon, MD
Dr. David Gannon, MD is a Family Medicine healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477534816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Gannon, MD has received a total of $11,717 in payments from pharmaceutical and medical device companies, with $1,555 received in 2024. These payments were reported across 696 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($11,581).
As a Medicare-enrolled provider, Gannon has provided services to 4,592 Medicare beneficiaries, totaling 5,830 services with total Medicare billing of $396,834. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Chandler, AZ
- Active Since 11/11/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1477534816
Products in Payments
- FARXIGA (Drug) $893.00
- JARDIANCE (Drug) $473.12
- NURTEC ODT (Drug) $326.69
- XARELTO (Drug) $322.57
- Ozempic (Drug) $312.80
- ELIQUIS (Drug) $291.54
- VRAYLAR (Drug) $267.35
- MOUNJARO (Drug) $244.34
- TRULICITY (Drug) $238.18
- Rybelsus (Drug) $230.31
- CHANTIX (Drug) $226.41
- Vascepa (Drug) $223.64
- UBRELVY (Drug) $199.68
- SYNTHROID (Drug) $199.57
- QULIPTA (Drug) $184.36
- SPIRIVA RESPIMAT (Drug) $182.64
- Saxenda (Drug) $179.42
- Aimovig (Biological) $175.31
- XIFAXAN (Drug) $175.12
- MYRBETRIQ (Drug) $170.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chandler
Jessica Blanco, Md, MD
Family Medicine — Payments: $371,097
Neil Sheth, Md, MD
Family Medicine — Payments: $52,983
Dr. Richard Le, D.o, D.O
Family Medicine — Payments: $26,429
Mr. Ronald Sell, Md, MD
Family Medicine — Payments: $22,702
Dr. Cynthia Jordan, M.d, M.D
Family Medicine — Payments: $16,693
Larry Tamburro, Md, MD
Family Medicine — Payments: $12,007